Iovance Biotherapeutics, Inc. (IOVA), a company focused on polyclonal tumor-infiltrating lymphocyte therapies for cancer patients, said on Tuesday that it has appointed Corleen Roche as Chief Financial Officer with effect from August 6.
Roche will replace Jean-Marc Bellemin, who had stepped down from his role on July 10.
Most recently, Roche served as CFO of CG Oncology, a late-stage clinical biopharmaceutical company.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.